PAGANINI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.082
EU - Europa 649
AS - Asia 134
AF - Africa 1
Totale 1.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.080
PL - Polonia 266
IE - Irlanda 105
SE - Svezia 91
IT - Italia 69
HK - Hong Kong 48
CN - Cina 43
DE - Germania 38
JO - Giordania 26
UA - Ucraina 21
GB - Regno Unito 19
FI - Finlandia 14
RU - Federazione Russa 7
BE - Belgio 6
FR - Francia 5
SG - Singapore 4
TR - Turchia 4
VN - Vietnam 4
ES - Italia 3
CA - Canada 2
CH - Svizzera 2
IN - India 2
TW - Taiwan 2
HU - Ungheria 1
KR - Corea 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
Totale 1.866
Salva come PNG Salva come JPEG
Città #
Warsaw 266
Fairfield 153
Chandler 120
Dublin 105
Ashburn 84
Woodbridge 80
Cambridge 63
Seattle 63
Wilmington 61
Houston 51
Ann Arbor 41
Jacksonville 41
Altamura 36
Lawrence 36
Hong Kong 30
Princeton 28
Beijing 20
Buffalo 18
Medford 15
Boston 13
Dearborn 13
Boardman 10
Kent 10
Florence 9
Shanghai 9
Brussels 6
Falls Church 6
New York 6
Moscow 5
Norwalk 5
Dong Ket 4
Hefei 4
Izmir 4
San Diego 4
West Jordan 4
Milan 3
Nanjing 3
Andover 2
Auburn Hills 2
Barcelona 2
Bern 2
Bremen 2
Hillsboro 2
Jinan 2
Munich 2
Palermo 2
Redwood City 2
Salerno 2
Taipei 2
Toronto 2
Acton 1
Brescia 1
Calenzano 1
Columbia 1
Frankfurt Am Main 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Islington 1
Jaipur 1
Kilburn 1
London 1
Madrid 1
Maglod 1
Nürnberg 1
Padova 1
Paris 1
Phoenix 1
Prescot 1
Redmond 1
San Francisco 1
San Giuliano Terme 1
San Mateo 1
Seoul 1
Shenzhen 1
Signa 1
Sindelfingen 1
Singapore 1
Southwark 1
Tappahannock 1
Wenzhou 1
Wuhan 1
Totale 1.487
Salva come PNG Salva come JPEG
Nome #
Time perception impairment in early-to-moderate stages of Huntington's disease is related to memory deficits 228
Huntington’s disease and Scalar Expectancy Theory: A memory-based time perception deficit 173
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 121
Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. 96
Identification of new presenilin gene mutations in early-onset familial Alzheimer disease 83
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion 82
Clinical and genetic characteristics of late-onset Huntington's disease 79
Suicidal ideation in a European Huntington's disease population 78
Reply to Josef Finsterer “MELAS requires broad clinical and genetic work-up” 76
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease 76
Therapeutic options in a patient with MELAS and diabetes mellitus: follow-up after 6 months of treatment 71
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 71
null 67
Discrepancies in reporting the CAG repeat lengths for Huntington's disease 65
SEMANTIC ACCESS AND LONG TERM MEMORY: A COMPARISION BETWEEN PARKINSONS DISEASE DE NOVO AND AGE ASSOCIATED MEMORY IMPAIRMENT. 62
DEEP BRAIN STIMULATION IN PATIENTS AFFECTED BY PARKINSON'S DISEASE: A COMPARISION BETWEEN NEUROPSYCHOLOGICAL EVALUATION BEFORE AND AFTER SURGERY 55
Evaluation of cognitive and language side effects of topiramate in patients with epilepsy, and effectiveness of counseling and speech therapy interventions 55
Differential diagnosis between epilepsy and syncope. The Oesys study (overlapping between epilepsy and syncope study): Preliminary results 50
Efficacia di una batteria specifica per la valutazione del danno lobare in pazienti con epilessia focale 43
Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs 43
Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy 42
Response: Brightening the crystal ball: A constructive reappraisal of the postwithdrawal seizure relapse prediction model 41
Guidelines for the diagnosis of dementia and Alzheimer's disease 38
Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment. 38
Assessment of distinctive neuropsychological impairment in frontal and temporal lobe epilepsy. 37
The spectrum of auto-immune encephalitis: Clinical characterisation and comparison between different syndromes defined by 2016 diagnostic criteria 29
Totale 1.899
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019106 0 0 0 0 0 0 0 0 0 0 59 47
2019/2020425 30 32 11 36 49 53 56 53 38 25 35 7
2020/2021199 22 17 10 22 7 27 11 17 18 21 8 19
2021/2022187 7 25 13 8 4 12 9 12 6 9 34 48
2022/2023530 39 113 38 20 43 83 68 21 80 5 9 11
2023/2024172 9 24 24 10 17 12 8 44 3 9 12 0
Totale 1.899